Tom 12, Nr 4 (2017)
CHOROBY STRUKTURALNE SERCA
Opublikowany online: 2017-09-20
Wyświetlenia strony
422
Wyświetlenia/pobrania artykułu
6332
Leczenie przezskórne koarktacja aorty — krok po kroku
Kardiol Inwazyjna 2017;12(4):25-31.
Streszczenie
Koarktacja aorty jest jedną z najczęstszych wrodzonych wad serca. Jej manifestacja może być dramatyczna w okresie noworodkowym lub podstępna, skąpoobjawowa w wieku późniejszym. Opóźnione postawienie diagnozy pogarsza rokowanie. Na przestrzeni ostatnich 60 lat zmieniło się podejście do leczenia tej wady. Odchodzono od tradycyjnych metod kardiochirurgicznych na rzecz nowoczesnych zabiegów przezskórnych. Celem niniejszej pracy było opisanie podstawowych zagadnień związanych z rozpoznaniem koarktacji aorty oraz kwalifikacją pacjentów do leczenia. Szczegółowo przedstawiono techniki zabiegów przezskórnych oraz dokonano przeglądu literatury pod kątem oceny wyników leczenia.
Słowa kluczowe: koarktacja aortyleczenie przezskórne
Referencje
- Campbell M. Natural history of coarctation of the aorta. Br Heart J. 1970; 32(5): 633–640.
- Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002; 39(12): 1890–1900.
- Harris KC, Du W, Cowley CG, et al. Congenital Cardiac Intervention Study Consortium (CCISC). A prospective observational multicenter study of balloon angioplasty for the treatment of native and recurrent coarctation of the aorta. Catheter Cardiovasc Interv. 2014; 83(7): 1116–1123.
- Kim JiE, Kim EK, Kim WH, et al. Abnormally extended ductal tissue into the aorta is indicated by similar histopathology and shared apoptosis in patients with coarctation. Int J Cardiol. 2010; 145(2): 177–182.
- Baumgartner H, Bonhoeffer P, De Groot NMS, et al. Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC), Association for European Paediatric Cardiology (AEPC), ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010; 31(23): 2915–2957.
- Lock JE, Castaneda-Zuniga WR, Bass JL, et al. Balloon dilatation of excised aortic coarctations. Radiology. 1982; 143(3): 689–691.
- O'Laughlin MP, Slack MC, Grifka RG, et al. Implantation and intermediate-term follow-up of stents in congenital heart disease. Circulation. 1993; 88(2): 605–614.
- Guidelines for the Management of Congenital Heart Diseases in Childhood and Adolescence. Cardiology in the Young. 2017; 27(S3): S1–S105.
- Seto AH, Abu-Fadel MS, Sparling JM, et al. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). JACC Cardiovasc Interv. 2010; 3(7): 751–758.
- Quandt D, Ramchandani B, Bhole V, et al. Initial experience with the cook formula balloon expandable stent in congenital heart disease. Catheter Cardiovasc Interv. 2015; 85(2): 259–266.
- Haji Zeinali AM, Sadeghian M, Qureshi SA, et al. Midterm to long-term safety and efficacy of self-expandable nitinol stent implantation for coarctation of aorta in adults. Catheter Cardiovasc Interv. 2017 [Epub ahead of print].
- Reich O, Tax P, Bartáková H, et al. Long-term (up to 20 years) results of percutaneous balloon angioplasty of recurrent aortic coarctation without use of stents. Eur Heart J. 2008; 29(16): 2042–2048.
- Forbes TJ, Garekar S, Amin Z, et al. Congenital Cardiovascular Interventional Study Consortium (CCISC). Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age: a multi-institutional study. Catheter Cardiovasc Interv. 2007; 70(2): 276–285.
- Rao PS, Galal O, Smith PA, et al. Five- to nine-year follow-up results of balloon angioplasty of native aortic coarctation in infants and children. J Am Coll Cardiol. 1996; 27(2): 462–470.
- Fawzy ME, Awad M, Hassan W, et al. Long-term outcome (up to 15 years) of balloon angioplasty of discrete native coarctation of the aorta in adolescents and adults. J Am Coll Cardiol. 2004; 43(6): 1062–1067.
- Forbes TJ, Kim DW, Du W, et al. CCISC Investigators. Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J Am Coll Cardiol. 2011; 58(25): 2664–2674.
- Forbes TJ, Moore P, Pedra CAC, et al. Intermediate follow-up following intravascular stenting for treatment of coarctation of the aorta. Catheter Cardiovasc Interv. 2007; 70(4): 569–577.
- van den Hoven AT, Duijnhouwer AL, Eicken A, et al. Adverse outcome of coarctation stenting in patients with Turner syndrome. Catheter Cardiovasc Interv. 2017; 89(2): 280–287.
- Sohrabi B, Jamshidi P, Yaghoubi A, et al. Comparison between covered and bare Cheatham-Platinum stents for endovascular treatment of patients with native post-ductal aortic coarctation: immediate and intermediate-term results. JACC Cardiovasc Interv. 2014; 7(4): 416–423.
- Canniffe C, Ou P, Walsh K, et al. Hypertension after repair of aortic coarctation--a systematic review. Int J Cardiol. 2013; 167(6): 2456–2461.
- Luijendijk P, Bouma BJ, Vriend JWJ, et al. Usefulness of exercise-induced hypertension as predictor of chronic hypertension in adults after operative therapy for aortic isthmic coarctation in childhood. Am J Cardiol. 2011; 108(3): 435–439.
